What is ROMPOST 250? ROMPOST 250 is a prescription injectable medicine containing: Generic Name: Romiplostim Strength: 250 mcg Dosage Form: Lyophilized powder for injection Route of Administration: Subcutaneous injection Therapeutic Category: Hematology Manufacturer: Cordium Pharmaceuticals Pvt. Ltd. This medicine should be administered only under the supervision of a qualified healthcare professional. Indications ROMPOST 250 is indicated for: Chronic Immune Thrombocytopenia (ITP) Treatment of adult and pediatric patients with chronic immune thrombocytopenia who have had an inadequate response to: Corticosteroids Immunoglobulins Splenectomy (when applicable) Romiplostim is not intended to normalize platelet counts but to maintain platelet levels sufficient to reduce bleeding risk. How ROMPOST 250 Works ROMPOST 250 contains Romiplostim, a thrombopoietin (TPO) receptor agonist. It works by: Binding to thrombopoietin receptors on bone marrow cells. Stimulating megakaryocyte growth and development. Increasing platelet production. Helping maintain safe platelet levels and reducing bleeding episodes. Key Benefits of ROMPOST 250 ✔ Increases platelet production ✔ Helps reduce bleeding risk ✔ Weekly dosing regimen ✔ Effective in chronic ITP patients unresponsive to standard treatments ✔ Personalized dose adjustment based on platelet counts ✔ Supports long-term disease management under specialist supervision Dosage & Administration Administered as a subcutaneous injection once weekly Initial and maintenance doses are determined by the physician based on body weight and platelet response Regular platelet count monitoring is essential Maximum dose adjustments should be made according to clinical guidelines Important: Do not self-administer unless specifically instructed by a healthcare provider. Storage Information Store according to label instructions: Refrigerate at 2°C to 8°C Do not freeze Protect from light Keep out of reach of children Possible Side Effects Common side effects may include: Headache Joint pain Dizziness Insomnia Muscle pain Abdominal discomfort Tingling sensations (paresthesia) Seek immediate medical attention if serious symptoms occur, including signs of blood clots or severe allergic reactions. Precautions Inform your healthcare provider if you have: History of blood clots Liver disease Kidney disease Bone marrow disorders Bleeding disorders Pregnancy or breastfeeding considerations Close monitoring is recommended during treatment. Why Choose Cordium Pharmaceuticals Pvt. Ltd.? Cordium Pharmaceuticals Pvt. Ltd. is committed to delivering high-quality specialty therapies focused on improving patient outcomes. Our Commitment Stringent quality standards Advanced manufacturing practices Reliable oncology and hematology portfolio Regulatory compliance Patient-centric healthcare solutions Frequently Asked Questions (FAQs) What is ROMPOST 250 used for? ROMPOST 250 is used for treating Chronic Immune Thrombocytopenia (ITP) in patients who have not responded adequately to other therapies. How does Romiplostim work? Romiplostim stimulates the body's thrombopoietin receptors to increase platelet production. Is ROMPOST 250 a chemotherapy medicine? No. ROMPOST 250 is a thrombopoietin receptor agonist used in hematology. Can patients self-administer ROMPOST 250? Administration should only be done under healthcare professional guidance. How often is ROMPOST 250 given? It is typically administered once weekly, with dosing individualized based on platelet counts.